Landscapes / Targets
DNA
17 drugs act on DNA, in 26 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs17
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Metastatic Ocular Melanoma, Metastatic Uveal Melanoma and 2 more | ||||
| Open drug page | |||||
Triazaacenaphthylene bacterial type II topoisomerase inhibitor |
Approved | 17 May 2027Phase 1 trial completes | |||
| Next date | 17 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Urinary Tract Infections | ||||
| Open drug page | |||||
Alkylating drug |
Approved | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Jan 2027Phase 2 trial completes | |||
| Next date | 31 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Malignant Melanoma, Melanoma (Skin) and 6 more | ||||
| Open drug page | |||||
SyB V-1901not checked |
— |
Phase 3 | 31 Jan 2028Phase 3 trial completes | ||
| Next date | 31 Jan 2028 · Phase 3 trial completes | ||||
| Also tested for | Adenovirus Infections | ||||
| Open drug page | |||||
Zimoxinnot checked |
— |
Phase 2/3 | Oct 2030Phase 2/3 trial completes | ||
| Next date | Oct 2030 · Phase 2/3 trial completes | ||||
| Also tested for | Endophthalmitis | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Adult, Solid Tumor and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2028Phase 1/2 trial completes | |||
| Next date | 30 Jun 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Novartis · Public NVS |
Phase 1/2 | 10 Jul 2028Phase 1/2 trial completes | ||
| Next date | 10 Jul 2028 · Phase 1/2 trial completes | ||||
| Also tested for | PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy | ||||
| Open drug page | |||||
Env /gag DNA Vaccinenot checked |
— |
Phase 2 | 31 Aug 2028Phase 2 trial completes | ||
| Next date | 31 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | HIV Prevention | ||||
| Open drug page | |||||
Methoxsalennot checked |
Photoactivated radical Generator; psoralen |
Phase 2 | Dec 2028Phase 2 trial completes | ||
| Next date | Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Colitis, Hepatitis and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Neoplasms | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2026Phase 1 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 31 May 2027Phase 1 trial completes | |||
| Next date | 31 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2028Phase 1 trial completes | |||
| Next date | 30 Nov 2028 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Lymphomas, Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Solid Tumor, Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 13 of 17 drugs. The other 4 are marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026